bifeprunox has been researched along with sarizotan in 1 studies
| Studies (bifeprunox) | Trials (bifeprunox) | Recent Studies (post-2010) (bifeprunox) | Studies (sarizotan) | Trials (sarizotan) | Recent Studies (post-2010) (sarizotan) |
|---|---|---|---|---|---|
| 30 | 1 | 12 | 26 | 7 | 5 |
| Protein | Taxonomy | bifeprunox (IC50) | sarizotan (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.006 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.006 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.006 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.006 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourdiol, N; Colpaert, F; Cuisiat, S; Lacharme, V; Newman-Tancredi, A; Vacher, B | 1 |
1 other study(ies) available for bifeprunox and sarizotan
| Article | Year |
|---|---|
Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Benzylamines; Dopamine D2 Receptor Antagonists; HeLa Cells; Humans; Radioligand Assay; Rats; Serotonin 5-HT1 Receptor Agonists; Signal Transduction; Stereoisomerism; Structure-Activity Relationship | 2007 |